Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Labetalol or Nifedipine

Phase 1Small molecule

UUniversity of Alabama at Birmingham

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[3][1]

Indication

Hypertension in PregnancyRecruiting

Hypertension in PregnancyPhase 1

Recruiting

Timeline

Expected Milestones

Q4 2026

Phase 1Recruiting

Hypertension in Pregnancy

NCT05989581

Clinical

Trials by Indication[1]

Hypertension in Pregnancy1 trial

Treatment of American Heart Association/American College of Cardiology Stage 1 Hypertension in Pregnancy: A Randomized Control Trial

Recruiting·UUniversity of Alabama at Birmingham·Phase 1·NCT05989581·74 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Labetalol or Nifedipine. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Labetalol or Nifedipine compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Labetalol or Nifedipine. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University of Alabama at Birmingham company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 1[1]
Company: UUniversity of Alabama at Birmingham

Related News